An observational study in Spinal Cord Injuries, sponsored by Hospital Nacional de Parapléjicos de Toledo. Completed at 2 sites in 2 countries. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-21.
Sponsored by Hospital Nacional de Parapléjicos de Toledo · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Spinal Cord Injuries with a site in Germany — 3 open to participants now, 6 under way, none of them phase 3. Spinal Cord Injuries · Germany.
Among the 22 studies in Spinal Cord Injuries with a site in Germany, this one is one of 3 that started in 2014, is one of 8 observational ones, and was the 9th registered.
2,028 studies on the registry are indexed under Spinal Cord Injuries; 540 are open to participants now.
Browse Spinal Cord Injuries studies →3 of the 22 studies in Spinal Cord Injuries with a site in Germany are open now. Recruiting first, the newest first:
NovaGo Therapeutics AG · Sites in Germany, Switzerland
Ages 18–75
AO Foundation, AO Spine · Sites in Germany, United States, Australia and 5 more countries
Ages 19+
St George's, University of London · Sites in Germany, Austria, Belgium and 9 more countries
Ages 16+
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 376 Spinal Cord Injuries studies recruiting now, 167 (44%) set no upper age limit and 158 (42%) stop at 75 or younger; 41 take children under 18; 52 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 3 started in 2014.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 110 is above the median of 60 across 333 observational studies indexed under Spinal Cord Injuries.
Median enrollment 38 across the 14 interventional studies, 185 across the 8 observational. Of the 15 that completed or were terminated, 1 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 22 have an industry lead sponsor. The 10 most frequent:
Hospital Nacional de Parapléjicos de Toledo is the lead sponsor of 6 studies on the registry; none are open to participants now.
Hospital Nacional de Parapléjicos de Toledo has 6 studies filed under Spinal Cord Injuries — fewer than ten, so there is no comparison to draw.
1 of the studies in Spinal Cord Injuries with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06817577NovaGo Therapeutics AGNG004 in Spinal Cord Injury Patients | 2027-03 |
Add it to your calendar (.ics) → With an account.
Among the 22 studies in Spinal Cord Injuries with a site in Germany, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to determine the autoantibody profiles after spinal cord injury and their role in spontaneous functional recovery.
Most patients experience variable degrees of functional recovery after spinal cord injury (SCI), predominantly in the first months after lesion. In SCI animal models, autoantibodies are pathogenic and their titers rise up at the time when spontaneous recovery stops. The aim of this study is to determine the autoantibody profiles after SCI and to infer their relation with functional recovery. To achieve this, autoantibody profiles, biochemical, hematological and immune-related parameters (cytokines, chemokines and growth factors) will be determined from a serum blood sample and functional recovery will be evaluated accordingly to standardized scales.
Patients with acute spinal cord injury admitted to the Spanish National Hospital for Paraplegics
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Autoimmune disease
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients (n=90) will undergo a common arm blood collection to determine autoantibody profiles in serum. This procedure will be performed twice: after recruitment and 3 months later.
Other: Blood collection
Control subjects (n=20) will undergo a common arm blood collection to determine autoantibody profiles in serum. This procedure will be performed only once.
Other: Blood collection
Blood collection from the subject's arm
Changes in ASIA scores
Time frame: 4 months
Change in neurological level of injury
Time frame: 4 months
Change in ASIA impairment scale (AIS)
Time frame: 4 months
Spinal cord independence measure (SCIM)
Time frame: Until discharge from the hospital (6-12 months)
Ran from Oct 2014 to primary completion in Dec 2020, 74 months.
Of 124 non-industry observational studies under Spinal Cord Injuries, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 74. This study's 74 months is above that.
Counting every sponsor, half of 135 studies reached it within 39 months; a quarter within 16 and three quarters within 82.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 21, 2026: primary completion Apr 2018 → Dec 2020 and completion Apr 2018 → Dec 2020.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital Nacional de Parapléjicos de Toledo